Taxol (paclitaxel) was approved by FDA for the treatment of patients with recurrent ovarian cancer

A. W. Menzin, S. A. King, J. K. Aikins, J. J. Mikuta, S. C. Rubin

Research output: Contribution to journalLetterpeer-review

19 Scopus citations
Original languageEnglish
Pages (from-to)103
Number of pages1
JournalGynecologic Oncology
Volume54
Issue number1
StatePublished - 1994

Keywords

  • Adenocarcinoma/drug therapy
  • Aged
  • Female
  • Humans
  • Paclitaxel/therapeutic use
  • Salvage Therapy
  • Skin Neoplasms/drug therapy
  • Uterine Cervical Neoplasms/drug therapy

Fingerprint

Dive into the research topics of 'Taxol (paclitaxel) was approved by FDA for the treatment of patients with recurrent ovarian cancer'. Together they form a unique fingerprint.

Cite this